Supreme Court: Ad Valorem Court Fees Apply to Appeals Seeking Statutory Land Acquisition Benefits  ||  Supreme Court: Cruise Voyages Remain Shipping Business under Section 44B Despite Onboard Services  ||  Supreme Court: People Abandon Cattle on Roads But Object to Their Use For Food  ||  Supreme Court Stays CIC Decision Declaring NSE Subject to the RTI Act  ||  SC: Wife May Be Denied Interim Maintenance if Husband Ex Facie Establishes Adultery  ||  SC: Prior Testimony is Inadmissible without Section 299 CrPC Order against Absconder  ||  Supreme Court: Administrative Action Can't Be Invalidated Solely for Lacking Formal Order  ||  Calcutta High Court: Section 141 NI Act Does Not Apply to Sole Proprietorships  ||  Orissa High Court Criticizes Magistrate for Defying Direction in Cheque Bounce Case  ||  Delhi High Court Safeguards Yuvraj Singh's Personality Rights, Orders Deepfake Takedown    

Bombay High Court Protects ‘MEFTAL-SPAS’, Restrains Use of Similar Drug Brand - (19 Jun 2026)

INTELLECTUAL PROPERTY RIGHTS

Bombay HC permanently restrained Alto Healthcare from using the ‘MEFIAL-SPAS’ mark for pain-relief medicine, ruling it deceptively similar to Blue Cross Laboratories’ ‘MEFTAL-SPAS’ trademark. The court held that the name, packaging and overall appearance could mislead consumers, chemists & doctors.

Tags : MEFTAL-SPAS; TRADEMARK; PROTECTS  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved